Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
Titel:
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer
Auteur:
Schrock, A.B. Ouyang, C. Sandhu, J. Sokol, E. Jin, D. Ross, J.S. Miller, V.A. Lim, D. Amanam, I. Chao, J. Catenacci, D. Cho, M. Braiteh, F. Klempner, S.J. Ali, S.M. Fakih, M.